Healthcare Services India

India Ketamine Clinics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

India Ketamine Clinics Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $74.9 Mn Placeholder estimate
Estimate 2025 $84.7 Mn 2.2% of the global market
Projected 2034 $254.3 Mn 200.4% Adds $169.7 Mn over 9 forecast years
CAGR 2025–2034 13.0% Faster than 62% of 107 Healthcare Services markets here
Key players 5
  • India is 2.19% of the global market.
  • In APAC, the largest is China at $292.9 Mn.
  • Fastest growing: India (this report) at 13% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$169.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Ketamine Clinics Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $74.9 Mn — —
2025 (base) $84.7 Mn +$9.7 Mn —
2026 (forecast) $95.7 Mn +$11.0 Mn +13%
2027 (forecast) $108.1 Mn +$12.4 Mn +27.7%
2028 (forecast) $122.2 Mn +$14.1 Mn +44.3%
2029 (forecast) $138.0 Mn +$15.9 Mn +63%
2030 (forecast) $156.0 Mn +$17.9 Mn +84.2%
2031 (forecast) $176.3 Mn +$20.3 Mn +108.2%
2032 (forecast) $199.2 Mn +$22.9 Mn +135.3%
2033 (forecast) $225.1 Mn +$25.9 Mn +165.8%
2034 (forecast) $254.3 Mn +$29.3 Mn +200.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

India Ketamine Clinics Market Analysis at a glance
Market size, 2025$84.7 Mn placeholder estimate
Forecast, 2034$254.3 Mn placeholder estimate
Growth (CAGR), 2025–203413.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, indication and end user (see all)
Key playersJohnson & Johnson, Klarity Health, Mindbloom, Nushama, Novamind (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Ketamine Clinics Market Analysis Executive Summary

Ketamine clinics give ketamine or esketamine treatments under medical supervision for depression and other mental health conditions.

Key segments of the ketamine Clinics market include treatment (IV Ketamine, Intranasal Esketamine and Ketamine-Assisted Psychotherapy) and indication (Depression, PTSD and Chronic Pain).

Bar chart: India Ketamine Clinics market size, 2024–2034, placeholder estimates. $74.9 Mn in 2024, $84.7 Mn in 2025 and $254.3 Mn in 2034, 13.0% CAGR.
India Ketamine Clinics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Ketamine Clinics Market Dynamics

Market Growth Drivers

More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the ketamine Clinics market. Governments and employers are investing more in mental health care.

Opportunity

Digital tools, new drug classes and care built into primary care and workplaces give the ketamine Clinics market strong room to grow worldwide.

Market Restraints

Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the ketamine Clinics market.

Competitive Landscape for Ketamine Clinics Market in India

The ketamine Clinics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Ketamine Clinics Market in India

Ketamine Clinics in India: payment and health figures

Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year.⁠[1] Suicide rate: 14.0 per 100,000 people in 2023, the latest WHO figure for India.⁠[2]

[1] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[2] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 21 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how ketamine Clinics services are delivered and paid for in India. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Ketamine Clinics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Ketamine Clinics in context

India compared

  • Suicide rate: 14.0 per 100,000 people (2023). World: 9.2 per 100,000 people (2023). 3rd highest of the 17 countries we cover in APAC.[1]
  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 12th highest of the 17 countries we cover in APAC.[2]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 13th highest of the 17 countries we cover in APAC.[3]

[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Ketamine Clinics market in India?
Placeholder estimate: about $84.7 Mn in 2025, rising to about $254.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Ketamine Clinics market in India growing?
Placeholder estimate: about 13.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Ketamine Clinics market report cover?
The report splits the market by treatment (IV Ketamine, Intranasal Esketamine, Ketamine-Assisted Psychotherapy), indication (Depression, PTSD, Chronic Pain, Anxiety) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Ketamine Clinics market?
Key players include Johnson & Johnson, Klarity Health, Mindbloom, Nushama and Novamind.
What is driving the Ketamine Clinics market?
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the ketamine Clinics market. Governments and employers are investing more in mental health care.
How is healthcare paid for in India?
Ayushman Bharat PM-JAY gives eligible families hospital cover of up to ₹5 lakh a year. Source: National Health Authority (PM-JAY). Checked 14 Nov 2026.
What does WHO report for India?
Suicide rate: 14.0 per 100,000 people in 2023, the latest WHO figure. Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 21 Nov 2026.
How many people in India are 65 or older?
7.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 21 Nov 2026.
How much research is published on Ketamine Clinics?
PubMed lists 12 papers on Ketamine Clinics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in India

See all

Related on mental health

See the topic